APG Asset Management
WST icon

APG Asset Management’s West Pharmaceutical WST Stock Holding History

APG Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$276M Buy
1,267,282
+68,277
+6% +$17M 0.87% 21
2025
Q4 		$281M Sell
1,199,005
-214,693
-15% -$58.7M 0.8% 19
2025
Q3 		$316M Sell
1,413,698
-244,966
-15% -$59.5M 0.89% 16
2025
Q2 		$309M Buy
1,658,664
+96,525
+6% +$20.6M 0.92% 20
2025
Q1 		$324M Buy
1,562,139
+124,737
+9% +$34.4M 1% 21
2024
Q4 		$455M Sell
1,437,402
-871,445
-38% -$274M 1.27% 10
2024
Q3 		$621M Sell
2,308,847
-24,190
-1% -$7.41M 4.12% 5
2024
Q2 		$717M Sell
2,333,037
-4,661
-0.2% -$1.65M 1.28% 14
2024
Q1 		$857M Buy
2,337,698
+37,329
+2% +$13.8M 1.5% 8
2023
Q4 		$733M Buy
2,300,369
+193,452
+9% +$68.5M 1.43% 9
2023
Q3 		$791M Sell
2,106,917
-153,072
-7% -$59.2M 1.62% 6
2023
Q2 		$792M Sell
2,259,989
-125,292
-5% -$44.8M 1.6% 6
2023
Q1 		$761M Sell
2,385,281
-175,552
-7% -$51.3M 1.61% 4
2022
Q4 		$603M Buy
2,560,833
+243,363
+11% +$57.7M 1.15% 12
2022
Q3 		$582M Sell
2,317,470
-84,099
-4% -$25.6M 1.5% 9
2022
Q2 		$695M Sell
2,401,569
-137,599
-5% -$44.8M 1.63% 5
2022
Q1 		$937M Sell
2,539,168
-8,200
-0.3% -$3.21M 1.77% 5
2021
Q4 		$1.05B Buy
2,547,368
+7,500
+0.3% +$3.23M 1.78% 4
2021
Q3 		$930M Buy
2,539,868
+8,500
+0.3% +$3.58M 1.65% 4
2021
Q2 		$767M Buy
2,531,368
+190,900
+8% +$63.1M 1.3% 4
2021
Q1 		$561M Buy
2,340,468
+1,149,862
+97% +$329M 0.96% 14
2020
Q4 		$276M Buy
1,190,606
+680,085
+133% +$191M 0.45% 47
2020
Q3 		$120M Buy
510,521
+257,890
+102% +$68.2M 0.21% 128
2020
Q2 		$51.1M Buy
252,631
+67,440
+36% +$13.3M 0.09% 225
2020
Q1 		$28.2M Buy
185,191
+36,198
+24% +$5.57M 0.06% 330
2019
Q4 		$20M Buy
+148,993
New +$21.7M 0.03% 433

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

APG Asset Management's WST Position: Q1 2026 in Review

APG Asset Management increased its West Pharmaceutical (WST) stake by 5.7% in Q1 2026, buying an estimated $17M and bringing the position to 1,267,282 shares worth $276M. The position accounts for 0.87% of the portfolio, ranked #21.

APG Asset Management first reported a position in WST in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.05B in Q4 2021. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • APG Asset Management held 1,267,282 shares of West Pharmaceutical worth $276M as of Q1 2026.
  • APG Asset Management bought 68,277 West Pharmaceutical shares in Q1 2026, an estimated $17M.
  • West Pharmaceutical made up 0.87% of APG Asset Management's portfolio in Q1 2026, its #21 holding.
  • APG Asset Management first reported a position in West Pharmaceutical in Q4 2019 and has held it in 26 quarters since.
  • APG Asset Management's West Pharmaceutical position peaked at $1.05B in Q4 2021.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on APG Asset Management's 13F filing for Q1 2026, filed 13 May 2026.